The Role of MicroRNAs in the Chemoresistance of Breast Cancer

被引:78
作者
Wang, Jing [1 ]
Yang, Muyi [2 ]
Li, Yu [3 ]
Han, Bo [2 ,4 ]
机构
[1] Fourth Peoples Hosp Jinan, Dept Pathol, Jinan, Peoples R China
[2] Shandong Univ, Sch Med, Dept Pathol, Jinan 250012, Peoples R China
[3] Shandong Prov Mil Command, Dept Outpatient, Jinan 250013, Peoples R China
[4] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250100, Peoples R China
关键词
breast cancer; chemoresistance; microRNAs; EPITHELIAL-MESENCHYMAL TRANSITION; CELLS; RESISTANCE; METASTASIS; MECHANISMS; EXPRESSION; TARGETS; BIOLOGY;
D O I
10.1002/ddr.21275
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Breast cancer is the most prevalent malignancy in women with more than 1.3 million new cases every year worldwide. Chemotherapy is a critical therapeutic strategy for breast cancer, while chemoresistance remains a major obstacle to treatment success. In the past two decades, significant progress has been achieved in understanding drug resistance in breast cancer, involving drug efflux, alterations in DNA repair pathways, suppression of apoptosis as well as epithelial-mesenchymal transition, and cancer stem cells. However, more effective therapeutic targets and novel biomarkers are still urgently needed to improve the overall survival and refine the therapeutic strategy for breast cancer patients. MicroRNAs (miRNAs) play crucial roles in cellular processes, such as cell differentiation, proliferation, and apoptosis. The recent discovery of miRNAs in malignancy has provided new directions for research on mechanisms underlying response to chemotherapy. Furthermore, several studies have documented that selected miRNAs, such as miR-200c and miR-34a, may influence response to chemotherapy in several tumor types, including breast cancer. The use of miRNAs as therapeutic targets to overcome chemoresistance is currently under investigation. In this review, we summarize the roles of miRNAs in chemoresistance through multiple molecular mechanisms, and highlight the potential diagnostic and therapeutic applications of miRNAs in overcoming breast cancer chemoresistance. Drug Dev Res 76 : 368-374, 2015. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:368 / 374
页数:7
相关论文
共 35 条
[1]   MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer [J].
Bai, Wen-Dong ;
Ye, Xing-Ming ;
Zhang, Meng-Yao ;
Zhu, Hua-Yu ;
Xi, Wen-Jin ;
Huang, Xun ;
Zhao, Jiao ;
Gu, Bin ;
Zheng, Guo-Xu ;
Yang, An-Gang ;
Jia, Lin-Tao .
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) :1356-1368
[2]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   The microRNA.org resource: targets and expression [J].
Betel, Doron ;
Wilson, Manda ;
Gabow, Aaron ;
Marks, Debora S. ;
Sander, Chris .
NUCLEIC ACIDS RESEARCH, 2008, 36 :D149-D153
[5]   Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics [J].
Calcagno, Anna Maria ;
Salcido, Crystal D. ;
Gillet, Jean-Pierre ;
Wu, Chung-Pu ;
Fostel, Jennifer M. ;
Mumau, Melanie D. ;
Gottesman, Michael M. ;
Varticovski, Lyuba ;
Ambudkar, Suresh V. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (21) :1637-1652
[6]   Breast cancer chemoresistance: Emerging importance of cancer stem cells [J].
Chuthapisith, Suebwong ;
Eremin, Jennifer ;
El-Sheemey, Mohamed ;
Eremin, Oleg .
SURGICAL ONCOLOGY-OXFORD, 2010, 19 (01) :27-32
[7]   The biology of neoadjuvant chemotherapy for breast cancer [J].
Cleator, S ;
Parton, M ;
Dowsett, M .
ENDOCRINE-RELATED CANCER, 2002, 9 (03) :183-195
[8]  
Eroles P, 2015, CURR DRUG TARGETS
[9]   Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression [J].
Freres, Pierre ;
Josse, Claire ;
Bovy, Nicolas ;
Boukerroucha, Meriem ;
Struman, Ingrid ;
Bours, Vincent ;
Jerusalem, Guy .
JOURNAL OF CELLULAR PHYSIOLOGY, 2015, 230 (02) :473-481
[10]   MicroRNAs as therapeutic targets in chemoresistance [J].
Garofalo, Michela ;
Croce, Carlo M. .
DRUG RESISTANCE UPDATES, 2013, 16 (3-5) :47-59